---
title: 'An evaluation of the National Institutes of Health grants portfolio: identifying
  opportunities and challenges for multi-omics research that leverage metabolomics
  data'
date: '2022-04-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35488937/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220503211812&v=2.17.6
source: metablomics[MeSH Terms]
description: 'BACKGROUND: Through the systematic large-scale profiling of metabolites,
  metabolomics provides a tool for biomarker discovery and improving disease monitoring,
  diagnosis, prognosis, and treatment response, as well as for delineating disease
  mechanisms and etiology. As a downstream product of the genome and epigenome, transcriptome,
  and proteome activity, the metabolome can be considered as being the most proximal
  correlate to the phenotype. Integration of metabolomics data with other -omics ...'
---
BACKGROUND: Through the systematic large-scale profiling of metabolites, metabolomics provides a tool for biomarker discovery and improving disease monitoring, diagnosis, prognosis, and treatment response, as well as for delineating disease mechanisms and etiology. As a downstream product of the genome and epigenome, transcriptome, and proteome activity, the metabolome can be considered as being the most proximal correlate to the phenotype. Integration of metabolomics data with other -omics ...